長(zhǎng)治地區(qū)乙肝相關(guān)疾病直接經(jīng)濟(jì)負(fù)擔(dān)及其影響因素分析
發(fā)布時(shí)間:2018-10-10 07:20
【摘要】:目的了解長(zhǎng)治地區(qū)乙肝相關(guān)疾病直接經(jīng)濟(jì)負(fù)擔(dān)及其影響因素。方法對(duì)住院患者采用面對(duì)面深度訪談的方式進(jìn)行調(diào)查,采用多元逐步回歸分析乙肝相關(guān)疾病直接經(jīng)濟(jì)負(fù)擔(dān)的影響因素,使用SPSS16.0進(jìn)行統(tǒng)計(jì)分析。結(jié)果乙肝相關(guān)疾病直接經(jīng)濟(jì)負(fù)擔(dān)為17 462.01元,其中直接醫(yī)療費(fèi)用和直接非醫(yī)療費(fèi)用分別為15 978.30元和1 483.71元,各類(lèi)乙肝相關(guān)疾病的直接醫(yī)療費(fèi)用均大于直接非醫(yī)療費(fèi)用;直接經(jīng)濟(jì)負(fù)擔(dān)占家庭收入和人均收入的比重以原發(fā)性肝癌最高,分別為1.32和5.82倍;年齡、全家月均收入、是否使用抗病毒藥、有無(wú)自購(gòu)藥品是其主要影響因素。結(jié)論長(zhǎng)治地區(qū)乙肝相關(guān)疾病患者直接經(jīng)濟(jì)負(fù)擔(dān)沉重,降低住院費(fèi)用,控制藥品費(fèi)用,有效預(yù)防和控制病毒性感染,可緩解乙肝患者直接經(jīng)濟(jì)負(fù)擔(dān)。
[Abstract]:Objective to investigate the direct economic burden and its influencing factors of hepatitis B related diseases in Changzhi area. Methods Face-to-face in-depth interview was used to investigate the inpatients, and multiple stepwise regression analysis was used to analyze the factors influencing the direct economic burden of hepatitis B related diseases. SPSS16.0 was used to carry out statistical analysis. Results the direct economic burden of hepatitis B related diseases was 17 462.01 yuan, of which the direct medical expenses and direct non-medical expenses were 15 978.30 yuan and 1 483.71 yuan respectively. The direct medical expenses of all kinds of hepatitis B related diseases were higher than the direct non-medical expenses. The proportion of direct economic burden in household income and per capita income was the highest in primary liver cancer (1.32 and 5.82 times respectively), age, monthly income of the whole family, use of antiviral drugs and availability of self-purchased drugs were the main influencing factors. Conclusion the direct economic burden of patients with hepatitis B related diseases in Changzhi area is heavy, and the direct economic burden of patients with hepatitis B can be alleviated by reducing the cost of hospitalization, controlling the cost of drugs and effectively preventing and controlling viral infection.
【作者單位】: 山西省長(zhǎng)治醫(yī)學(xué)院預(yù)防醫(yī)學(xué)系;深圳市疾病預(yù)防控制中心;
【基金】:“十一五”國(guó)家科技重大專(zhuān)項(xiàng)(2008ZX10002-001)
【分類(lèi)號(hào)】:R512.62
[Abstract]:Objective to investigate the direct economic burden and its influencing factors of hepatitis B related diseases in Changzhi area. Methods Face-to-face in-depth interview was used to investigate the inpatients, and multiple stepwise regression analysis was used to analyze the factors influencing the direct economic burden of hepatitis B related diseases. SPSS16.0 was used to carry out statistical analysis. Results the direct economic burden of hepatitis B related diseases was 17 462.01 yuan, of which the direct medical expenses and direct non-medical expenses were 15 978.30 yuan and 1 483.71 yuan respectively. The direct medical expenses of all kinds of hepatitis B related diseases were higher than the direct non-medical expenses. The proportion of direct economic burden in household income and per capita income was the highest in primary liver cancer (1.32 and 5.82 times respectively), age, monthly income of the whole family, use of antiviral drugs and availability of self-purchased drugs were the main influencing factors. Conclusion the direct economic burden of patients with hepatitis B related diseases in Changzhi area is heavy, and the direct economic burden of patients with hepatitis B can be alleviated by reducing the cost of hospitalization, controlling the cost of drugs and effectively preventing and controlling viral infection.
【作者單位】: 山西省長(zhǎng)治醫(yī)學(xué)院預(yù)防醫(yī)學(xué)系;深圳市疾病預(yù)防控制中心;
【基金】:“十一五”國(guó)家科技重大專(zhuān)項(xiàng)(2008ZX10002-001)
【分類(lèi)號(hào)】:R512.62
【參考文獻(xiàn)】
相關(guān)期刊論文 前8條
1 王南松,孟s,
本文編號(hào):2261140
本文鏈接:http://sikaile.net/yixuelunwen/chuanranbingxuelunwen/2261140.html
最近更新
教材專(zhuān)著